As a GLP-1 receptor agonist, semaglutide mimics a natural hormone in your body that regulates appetite, blood sugar, and digestion
Those with a history of substance abuse or addiction require careful evaluation before being prescribed Adderall, and the addition of Wegovy to the mix does not change this fundamental concern
Brighten breaks down how perimenopause and menopause shift insulin sensitivity, fat distribution, appetite, and recovery and where glucagon-like peptide-1 (GLP-1) receptor agonists (think semaglutide/Ozempic, Wegovy, liraglutide, tirzepatide as a related incretin therapy) can fit safely alongside hormone therapy, lifting, protein, and smart lab work
JAMA 2023;330:163140.ArticlePubMedPMC 37
And younger consumers are amplifying every trend
Molecular Biology Laboratory studies continue exploring peptide-receptor binding mechanisms and downstream cellular signaling